Opioid control of MAP kinase cascade

Area of Science:

• Cellular signaling pathways
• Molecular pharmacology
• Neuroscience

Background:

• G protein-coupled receptors (GPCRs) activation can lead to extracellular signal-regulated kinases 1/2 (ERK 1/2) phosphorylation.
• This signaling often involves ectodomain shedding, producing epidermal growth factor (EGF)-like ligands that activate mitogen-activated protein kinase (MAPK) pathways via EGF receptors.

Purpose of the Study:

• To investigate the control of MAPK pathways by opioidergic GPCRs in human embryonic kidney (HEK 293) cells.
• To elucidate the specific EGF receptor subtypes involved in ERK activation downstream of opioid receptor stimulation.

Main Methods:

• Experiments utilized HEK 293 cells engineered to express opioid receptors, G protein-coupled receptor kinases, and ERKs.
• Investigated receptor internalization and ERK phosphorylation in response to EGF and opioid receptor agonists.

Main Results:

• Opioid receptor stimulation releases EGF-like ligands that activate ERK 1/2 through distinct EGF receptors, differing from EGF's direct activation via EGF receptor type 1.
• Mu-, delta-, and kappa-opioid receptors exhibit differential activation of ERKs.
• EGF rapidly internalizes EGF receptor type 1, whereas opioid receptor stimulation does not induce similar sequestration, indicating engagement of alternative EGF receptor types.

Conclusions:

• Opioidergic GPCRs modulate the MAPK cascade similarly to other GPCRs, with notable distinctions among mu, delta, and kappa receptor subtypes.
• EGF-induced ERK activation is mediated by EGF receptor type 1, while opioid receptor activation appears to involve a different EGF receptor type.